Verisante Technology Inc

PINK:VRSEF USA Medical Devices
Market Cap
$219.69K
Market Cap Rank
#42205 Global
#13671 in USA
Share Price
$0.01
Change (1 day)
+0.00%
52-Week Range
$0.01 - $0.01
All Time High
$0.07
About

Verisante Technology Inc. does not have significant operations. Previously, the company was involved in the design and manufacture of cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was incorporated in 2006 and is based in Vancouver, Canada.

Verisante Technology Inc (VRSEF) - Total Liabilities

Latest total liabilities as of September 2025: $162.52K USD

Based on the latest financial reports, Verisante Technology Inc (VRSEF) has total liabilities worth $162.52K USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Verisante Technology Inc - Total Liabilities Trend (2008–2024)

This chart illustrates how Verisante Technology Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Verisante Technology Inc Competitors by Total Liabilities

The table below lists competitors of Verisante Technology Inc ranked by their total liabilities.

Company Country Total Liabilities
TRANSOCEAN N - Dusseldorf Stock Exchang
DU:TOJ
Germany €9.28 Billion
RENTOKIL INITIAL (RTO1.SG)
STU:RTO1
Germany €7.04 Billion
Bearclaw Capital Corp
V:BRL-H
Canada CA$108.77K
CH SHENHUA ENGY -H- (IKF.SG)
STU:IKF
Germany €156.50 Billion
Marshalls PLC
LSE:MSLH
UK GBX430.70 Million
AS Harju Elekter
STU:HD8
Germany €70.26 Million

Liability Composition Analysis (2008–2024)

This chart breaks down Verisante Technology Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.18 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.04 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 28.99 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Verisante Technology Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Verisante Technology Inc (2008–2024)

The table below shows the annual total liabilities of Verisante Technology Inc from 2008 to 2024.

Year Total Liabilities Change
2024-12-31 $81.90K +73.89%
2023-12-31 $47.10K -49.44%
2022-12-31 $93.17K -94.54%
2021-12-31 $1.71 Million +23.63%
2020-12-31 $1.38 Million +3.34%
2019-12-31 $1.33 Million -16.50%
2018-12-31 $1.60 Million -42.92%
2017-12-31 $2.80 Million +8.54%
2016-12-31 $2.58 Million +23.53%
2015-12-31 $2.09 Million +34.63%
2014-12-31 $1.55 Million +126.06%
2013-12-31 $686.36K -13.52%
2012-12-31 $793.68K +15.46%
2011-12-31 $687.39K +336.53%
2010-12-31 $157.47K +76.02%
2009-12-31 $89.46K +126.20%
2008-12-31 $39.55K --